Cheryl M Lapriore
Biographic Data
| ID | 10000073 |
|---|---|
| NAME | Cheryl M Lapriore |
| GIVEN NAMES | Cheryl M |
| FAMILY NAME | Lapriore |
| SIGNATURE | LAPRIORE C M |
| AFFILIATIONS | UMass Memorial Health Care |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The mobile vaccine equity enhancement program–a model program for enhancing equity in vaccine availability based at a large health care system
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers t…
A Citywide Approach to Sars-CoV2 Testing
The COVID-19 pandemic caused more than 30 million infections in the United States between March 2020 and April 2021. In response to systemic disparities in SARS-CoV2 testing and COVID-19 infections, health systems, city leaders and community stakeholders in Worcester, Massachusetts created a citywide Equity Task Force with a specific goal of making low-barrier testing available to individuals throughout our community. Within months, the state of …
No prominent works on this page.
A Citywide Approach to Sars-CoV2 Testing
The COVID-19 pandemic caused more than 30 million infections in the United States between March 2020 and April 2021. In response to systemic disparities in SARS-CoV2 testing and COVID-19 infections, health systems, city leaders and community stakeholders in Worcester, Massachusetts created a citywide Equity Task Force with a specific goal of making low-barrier testing available to individuals throughout our community. Within months, the state of …
The mobile vaccine equity enhancement program–a model program for enhancing equity in vaccine availability based at a large health care system
The SARS CoV-2 (COVID-19) pandemic presented unprecedented challenges as communities attempted to respond to the administration of a novel vaccine that faced cold chain logistical requirements and vaccine hesitancy among many, as well as complicated phased rollout plans that changed frequently as availability of the vaccine waxed and waned. The COVID-19 pandemic also disproportionately affected communities of color and communities with barriers t…
Business (2 works) · COVID-19 epidemiological studies (2 works) · Disease (2 works) · Health care (2 works) · Medicine (2 works) · Pandemic (2 works) · Political science (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Economic growth (1 work) · Economics (1 work)